KeyMed – Talk Bio

Actionable Insights Powered by AI

InnoCare and KeyMed Secure $520M Licensing Deal for Bispecific Antibody with RTW-Built Biotech

3 months ago talkbio0Tagged Antibodies, Bispecific, InnoCare, Investments, KeyMed, Licensing, RTW

InnoCare, KeyMed, Bispecific Antibody, RTW Investments, Licensing Deal, $520M